secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-06-05T20:30:42+00:00
Accession:  0001213900-26-065850
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BiomX issues 1,013,637 shares on partial conversion of Mandragola note; grants 2M-share warrant
--------------------------------------------------------------------------------

- Issued 1,013,637 restricted shares upon partial conversion of $379K principal under 12% convertible note with Mandragola.
- Line of credit agreement dated May 13, 2026 provides up to $2M revolving credit at 12% annual interest.
- Issued five-year warrant to Mandragola to purchase 2M shares at $12.00 per share, subject to stockholder approval.
- Company now has 11,160,153 shares of common stock outstanding after conversion.
- Shares and warrant issued in reliance on Section 4(a)(2) exemption; no general solicitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026065850/0001213900-26-065850-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026065850/ea0293750-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-065850

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer